Licensing - Cellophil™
new generation of biomedical polymers
CIS Pharma has developed Cellophil™, a group of polyacryloyl-alpha-aminoacids
that show superior biocompatibility in comparison to polymers currently
used in biomedical applications such as PMMA, MMA, HEMA and the like.
Cellophil™ polymers improve the acceptance of many implants and
medical devices.
Download
Licensing - Drug Delivery System for Eye Care, ENT, Cosmetics
CIS Pharma has acquired co-marketing rights for Naturaceutical Delivery
Corporation's (NDC) Preservative Free Drug Delivery System. In co-operation
with NDC we offer complete product development in the fields of
ophthalmology, ENT, dermatology, cosmeceuticals and traditional
cosmetics.
Download
Investment - Suprofenac anti-inflammatory (NSAID) development
CIS Pharma has developed Suprofenac, a new non-steroidal anti-inflammatory
(NSAID) compound for the treatment of acute and chronic pain as
well as ocular inflammation.
Download
|
Christoph Schäfer, Licensing Business Development